Status:
UNKNOWN
Beat COVID-19 - Observational Trial
Lead Sponsor:
Beat COVID LLC
Conditions:
COVID-19
Eligibility:
All Genders
18-110 years
Brief Summary
JUPITER is an observational study protocol that aims to understand factors that can help prevent/mitigate the spread of COVID-19 and understand factors that help reduce disease progression in patients...
Detailed Description
This is an observational study that will electronically collect self-reported participant data in a database that follows HIPAA security requirements for those with a clinically confirmed case of COVI...
Eligibility Criteria
Inclusion
- Adults residing in the United States aged 18 years or older proficient in understanding and reading the English language who wish to participate in the fight against COVID-19 by providing self-reported health information.
- Ability to complete electronic informed consent process.
- Ability to use the internet and check email regularly.
- Consent to provide a HIPAA waiver of health information to share protected health information.
Exclusion
- 1\. Inability to provide regular updates to their health status when contacted by the BEAT COVID study personnel via email or SMS.
Key Trial Info
Start Date :
April 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT04337762
Start Date
April 6 2020
End Date
July 1 2021
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beat COIVD, LLC
Chicago, Illinois, United States, 60452